multitarget – Lab DB

King’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s Treatment

Rifan Muazin Jul 17, 2026 0

The landscape of neurodegenerative research has shifted significantly following a landmark discovery by scientists at King’s College London (KCL), who…

King’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s Treatment

YOU MAY HAVE MISSED

Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition

Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation